Efficacy of oligodendrocyte precursor cells as delivery vehicles for single-chain variable fragment to misfolded SOD1 in ALS rat model-Reference-Cited by-同舟云学术

Efficacy of oligodendrocyte precursor cells as delivery vehicles for single-chain variable fragment to misfolded SOD1 in ALS rat model

Published:2023-03 Issue: Volume:28 Page:312-329
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Minamiyama Sumio,Sakai Madoka,Yamaguchi Yuko,Kusui Makiko,Wada Hideki,Hikiami Ryota,Tamaki Yoshitaka,Asada-Utsugi Megumi,Shodai Akemi,Makino Akiko,Fujiwara Noriko,Ayaki Takashi,Maki Takakuni,Warita Hitoshi,Aoki Masashi,Tomonaga Keizo,Takahashi Ryosuke,Urushitani Makoto^ORCID

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference56 articles.

1. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis;Rosen;Nature,1993

2. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis;Pramatarova;Am. J. Hum. Genet.,1995

3. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management;Eisen;Amyotroph Lateral Scler.,2008

4. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study;Miller;Lancet Neurol.,2013

5. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis;Patel;Mol. Ther.,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update;Expert Opinion on Drug Discovery;2024-08-08

2. A novel antibody to treat SOD1-related amyotrophic lateral sclerosis;Molecular Therapy - Methods & Clinical Development;2023-06

3. Antibodies With Chaperone Function;PROG BIOCHEM BIOPHYS;2023